Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2024

Open Access 01-12-2024 | Gastrectomy | Research

Short-and long-term outcomes of one-stage versus two-stage gastrectomy for perforated gastric cancer: a multicenter retrospective propensity score-matched study

Authors: Junling Zhang, Kexuan Li, Zongnai Zhang, Guochao Zhang, Shupeng Zhang, Yinming Zhao, Zhaoya Gao, Haiyun Ma, Yong Xie, Jinsheng Han, Li Zhang, Baoliang Zhang, Yang Liu, Tao Wu, Yingchao Wu, Yi Xiao, Xin Wang

Published in: World Journal of Surgical Oncology | Issue 1/2024

Login to get access

Abstract

Objective

There is no scientific consensus about the treatment of perforated gastric cancer (PGC). Therefore, the aim of this study was to investigate which is the better treatment option for PGC between the single-stage and two-stage strategies.

Methods

All 81 PGC patients from 13 medical institutions were retrospectively enrolled in this study. The PGC patients who underwent R0 gastrectomy were divided into one-stage surgery and two-stage surgery groups. The clinicopathological characteristics of the two groups were compared, and 415 regular gastric cancer patients without perforation were randomly selected as a control. The propensity score matching (PSM) method was used to find matched regular GC patients with similar clinicopathological parameters. The OS (overall survival) and the number harvested lymph nodes from PGC patients and regular GC patients were compared.

Results

Compared with PGC patients who underwent one-stage surgery, those who underwent two-stage surgery harvested significantly more lymph nodes [31(27, 38) vs 17 (12, 24), P < 0.001], required less blood transfusion [0 (0, 100) vs 200 (0, 800), P = 0.034], had a shorter ICU stay [0 (0, 1.5) vs 3 (0, 3), P = 0.009], and had a significantly better OS (Median OS: 45 months vs 11 months, P = 0.007). Compared with propensity score-matched regular GC patients without perforation, PGC patients who underwent one-stage gastrectomy had a poorer quality of lymphadenectomy [17 (12, 24) vs 29 (21, 37), P < 0.001] and suffered a worse OS (Median OS: 18 months vs 30 months, P = 0.024). Conversely, two-stage gastrectomy can achieve a comparable quality of lymphadenectomy (P = 0.506) and a similar OS (P = 0.096) compared to propensity score-matched regular GC patients.

Conclusions

For PGC patients in poor condition, two-stage treatment is a better option when D2 radical gastrectomy cannot be achieved in emergency surgery, based on our findings that two-stage gastrectomy could provide PGC patients with a better quality of lymphadenectomy and a better OS.
Literature
2.
go back to reference Kasakura Y, Ajani JA, Fujii M, et al. Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg. 2002;68(5):434.CrossRefPubMed Kasakura Y, Ajani JA, Fujii M, et al. Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg. 2002;68(5):434.CrossRefPubMed
6.
go back to reference Sobin L, Gospodarowicz M, Wittekind C. TMN Classification of Malignant Tumours, Union for International Cancer Control (UICC) and Wiley [M]. Oxford: Blackwell; 2009. Sobin L, Gospodarowicz M, Wittekind C. TMN Classification of Malignant Tumours, Union for International Cancer Control (UICC) and Wiley [M]. Oxford: Blackwell; 2009.
10.
go back to reference Songun I, Putter H, Kranenbarg EM-K, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439–49.CrossRefPubMed Songun I, Putter H, Kranenbarg EM-K, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439–49.CrossRefPubMed
15.
go back to reference Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.CrossRefPubMed Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.CrossRefPubMed
16.
go back to reference Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.CrossRefPubMed Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.CrossRefPubMed
17.
go back to reference Bang Y-J, Kim Y-W, Yang H-K, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21.CrossRefPubMed Bang Y-J, Kim Y-W, Yang H-K, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21.CrossRefPubMed
23.
go back to reference Lu J, Zheng Z-F, Xie J-W, et al. Is the 8th edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549-patient international database study. Ann Surg Oncol. 2018;25(7):2002–11.CrossRefPubMed Lu J, Zheng Z-F, Xie J-W, et al. Is the 8th edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549-patient international database study. Ann Surg Oncol. 2018;25(7):2002–11.CrossRefPubMed
27.
go back to reference Zhu B-Y, Yuan S-Q, Nie R-C, et al. Prognostic factors and recurrence patterns in T4 gastric cancer patients after curative resection. J Cancer. 2019;10(5):1181.CrossRefPubMedPubMedCentral Zhu B-Y, Yuan S-Q, Nie R-C, et al. Prognostic factors and recurrence patterns in T4 gastric cancer patients after curative resection. J Cancer. 2019;10(5):1181.CrossRefPubMedPubMedCentral
Metadata
Title
Short-and long-term outcomes of one-stage versus two-stage gastrectomy for perforated gastric cancer: a multicenter retrospective propensity score-matched study
Authors
Junling Zhang
Kexuan Li
Zongnai Zhang
Guochao Zhang
Shupeng Zhang
Yinming Zhao
Zhaoya Gao
Haiyun Ma
Yong Xie
Jinsheng Han
Li Zhang
Baoliang Zhang
Yang Liu
Tao Wu
Yingchao Wu
Yi Xiao
Xin Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2024
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-023-03283-4

Other articles of this Issue 1/2024

World Journal of Surgical Oncology 1/2024 Go to the issue